Guanzhou (1)

Prophylactic HQP1351 Therapy (1)

Third Generation TKI (1)

Withdrawn (1)

phase 2 (1)

xuna (1)

Guangdong Second Provincial General Hospital (1)

Nanfang Hospital of Southern Medical University (1)

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)

Third Affiliated Hospital, Sun Yat-Sen University (1)

hqp1351( olverembatinib dimesylate) (1)

drug (1)

Other (1)

Interventional (1)

third generation tki

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Withdrawn

Guanzhou, China

Department of Hematology, Nanfang Hospital, Southern Medical Uni

Jan 16, 2023